ACADIA Pharmaceuticals Inc. vs Noble Corporation plc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Noble Corporation plc trades at $44.25 (market cap $7.10B). The key difference: Noble Corporation plc is the larger of the two by market cap, and Noble Corporation plc pays a 4.5% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | NE | |
|---|---|---|
Market Cap | $5.07B | $7.10B |
Sector | Health | Technology |
52-Week High | $29.41 | $54.37 |
52-Week Low | $20.06 | $26.61 |
Enterprise Value | $4.19B | $8.53B |
Dividend Yield | — | 4.5% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Noble Corporation plc is a leading offshore drilling contractor for the oil and gas industry. The company owns and operates a high-specification fleet of mobile offshore drilling units, including drillships and semi-submersibles, that are used for exploration and production activities in deepwater and harsh environments worldwide. Noble focuses on providing safe, efficient, and reliable drilling services to major and independent oil and gas companies globally.
Read more on NE →